课题基金 / 基金详情

Racial Disparities in Liver Diseases

Racial Disparities in Liver Diseases
肝脏疾病的种族差异
批准号:
7279805
负责人:
CHARLES D HOWELL
金额:
$18.86万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-30 至 2010-08-31
关键词:
AFP geneAbdomenAccountingAcuteAcute Hepatitis CAddressAdherenceAdverse effectsAdverse eventAfricanAfrican AmericanAftercareAge-YearsAlbuminsAlcohol consumptionAm 80Ancillary StudyAntibodiesAntiviral AgentsAntiviral TherapyAntiviral resistanceBehaviorBilirubinBiochemicalBioinformaticsBiological AssayBiological MarkersBiologyBiopsyBloodBlood Urea NitrogenBlood urea nitrogen measurementBostonCD4 Positive T LymphocytesCD8B1 geneCalendarCaliforniaCaucasiansCaucasoid RaceCeruloplasminCessation of lifeChemistryChicagoCholesterolChronicChronic Hepatitis CCirrhosisClassClinicalClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials DesignCoagulation ProcessCollectionCombined Modality TherapyComputer softwareComputersContraceptive methodsContractsCreatinineCytotoxic T-LymphocytesDNA Microarray ChipDNA Microarray formatDNA-Directed RNA PolymeraseDailyDataData Coordinating CenterDate/TimeDeath RateDetectionDevelopmentDigestive System DisordersDiseaseDisease OutcomeDisease ProgressionDoctor of PhilosophyDoseDropsDrug ExposureDrug KineticsEducationEducational process of instructingEffectivenessElectrocardiogramElectronicsElementsEligibility DeterminationEnd PointEnrollmentEpidemiologyEthicsEtiologyEventExhibitsFastingFemaleFemale of child bearing ageFerritinFrequenciesFundingFutureGenderGene ExpressionGenesGeneticGenetic TranscriptionGenomeGenomicsGenotypeGlucoseGoalsGrantHIVHealthHealth Care CostsHepaticHepatitis BHepatitis B Surface AntigensHepatitis CHepatitis C virusHepatocyteHigh PrevalenceHip region structureHistologyHourHumanImageImmuneImmune responseImmune systemImmunityImmunologyImmunotherapyIn VitroIncidenceIndianaIndividualInfectionInfectious Diseases ResearchInflammationInformed ConsentIngestionInjection of therapeutic agentInjuryInstructionInsulinIntakeIntegration Host FactorsInterferon-alphaInterferonsInterviewIronKineticsLabelLaboratoriesLettersLinkLiverLiver CirrhosisLiver diseasesLos AngelesLung diseasesLymphocyteMarylandMeasurementMeasuresMedicalMedical HistoryMedical centerMentorsMentorshipMetabolismMethodologyMichiganMicroarray AnalysisMicroprocessorMicroscopicMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchMinorityModelingMolecular ProfilingMonitorNational Cancer InstituteNational Institute of Diabetes and Digestive and Kidney DiseasesNonstructural ProteinNorth CarolinaNot Hispanic or LatinoNuclearNumbersOutcomeParticipantPathogenesisPathologistPathologyPatient CarePatient EducationPatient Self-ReportPatientsPatternPeer ReviewPegylated Interferon AlfaPeripheral Blood Mononuclear CellPharmaceutical PreparationsPhasePhosphotransferasesPilot ProjectsPlayPolymerase Chain ReactionPopulationPopulation StudyPregnancy TestsPrevalencePreventive MedicinePrimary carcinoma of the liver cellsPrincipal InvestigatorProblem SolvingProceduresProductionPropertyProtocols documentationPurposeQuality of lifeQuestionnairesRNARNA replicationRaceRateRecording of previous eventsRecordsRelative (related person)ReportingRequest for ProposalsResearchResearch DesignResearch PersonnelResearch Project GrantsResearch TrainingResistanceResolutionRibavirinRoleSafetySample SizeSamplingSan FranciscoScientistScoreScreening procedureSelf EfficacySelf ManagementSelf-AdministeredSeriesSerologic testsSerumSerum Total Iron-Binding Capacity resultServicesSex FunctioningSideSignal TransductionSocial supportSpecialistSpecific qualifier valueStagingStructureStudy of serumSurveysSymptomsSystemT-LymphocyteTechniquesTechnologyTelephoneTestingThoracic RadiographyThyroid GlandTimeTissue-Specific Gene ExpressionTissuesTrainingTransaminasesTreatment EfficacyTreatment FailureTreatment outcomeTriglyceridesUnited StatesUnited States Food and Drug AdministrationUniversitiesUric AcidUrinalysisUrineVariantVial deviceViralViral AntigensViral Drug ResistanceViral GenomeViral Load resultViral PhysiologyViral load measurementViremiaVirusVirus DiseasesVisitWeekWeightWomanYangalpha 1-Antitrypsinalpha-Fetoproteinsanti-hepatitis CbasecDNA Arrayscareercaucasian Americanchild bearingcohortcytokinedata miningdaydesigndrug testingefficacy evaluationenzyme linked immunospot assayfollow-upgastrointestinalgenetic risk factorhealth disparityillness lengthimprovedin vivoinclusion criteriainnovationinterestinterferon therapyintrahepaticliver biopsymalemedical schoolsmedication compliancemortalitynovelnucleasepatient orientedpatient oriented researchpeginterferon alfa-2apeginterferon alfa-2bperipheral bloodprofessorprogramsracial differenceresearch studyresponsesample collectionself esteemskillssocialsuccesstherapy adherencetherapy resistanttooltouchscreentreatment durationvaccine developmentviral RNAvirologyvirus genetics

项目摘要

项目成果

CHARLES D HOWELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The applicant's long-term career objective is to decrease racial disparities in liver diseases in the United States by conducting well-designed patient-oriented research and by increasing the number of highly trained research scientists engaged in patient-oriented research in digestive diseases. Chronic hepatitis C virus (HCV) infection is the most common etiology for liver cirrhosis and a major cause for primary hepatocellular carcinoma (HCC) in the US. Several well-designed population studies have found a greater HCV prevalence and both a higher HCC incidence and mortality from primary hepatocellular carcinoma in Black Americans compared to White Americans. Ironically, Blacks have a much lower rate of HCV clearance during peginterferon plus ribavirin treatment. A better understanding of the causes for health disparities based on race is a necessary to develop comprehensive strategies to improve the health of racial minorities as well as the general US populace. Dr. Howell is an established investigator with an excellent track in patient-oriented research on racial disparities. His immediate career objectives are: 1) to develop a new patient-oriented research studies investigating the basis for racial disparities in liver disease; 2) to provide high-quality mentorship for the increasing numbers of trainees interested in patient-oriented liver research at the University of Maryland, including Gastrointestinal and Infectious Diseases research training grants; and 3) to strengthen his background for future patient-oriented research projects and mentoring by completing didactic coursework in clinical investigation. The Midcareer Investigator Award in Patient-Oriented Research (K24) award will enhance the applicant's career development and future success in patient-oriented research by allowing him to decrease his patient care, teaching, and institutional service obligations and to spend more time pursuing these important goals and objectives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RIBAVIRIN PHARMACOKINETICS, RACE AND OUTCOME OF HEPATITIS C TREATMENT
  • 批准号:
    7951172
  • 项目类别:
  • 资助金额:
    $3.15万
  • 财政年份:
    2009
  • 负责人:
    CHARLES D HOWELL
  • 依托单位:
Ribavirin Pharmacokinetics, Race and HCV Treatment
  • 批准号:
    7242435
  • 项目类别:
  • 资助金额:
    $22.28万
  • 财政年份:
    2007
  • 负责人:
    CHARLES D HOWELL
  • 依托单位:
Ribavirin Pharmacokinetics, Race and HCV Treatment
  • 批准号:
    7440199
  • 项目类别:
  • 资助金额:
    $18.19万
  • 财政年份:
    2007
  • 负责人:
    CHARLES D HOWELL
  • 依托单位:
STUDY OF VIRAL RESISTANCE TO ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C (VIRAHEP)
  • 批准号:
    7376926
  • 项目类别:
  • 资助金额:
    $2.38万
  • 财政年份:
    2006
  • 负责人:
    CHARLES D HOWELL
  • 依托单位:
海外基金